Pilot whole genome sequencing service: Bupa becomes first UK major private healthcare provider to pilot whole genome sequencing for selected UK customers, identifying risk of disease across more than 36 conditions including 10 cancers · ‘My Genomic Health’ begins as a two-year pilot offering more than 3,500 customers whole genome sequencing to identify their risk […]
Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic Acids Research, a recent study from the University of Eastern Finland Institute of Biomedicine suggests that the SIX2 protein may be a possible factor underlying increased plasticity of prostate cancer cells and treatment resistance. Prostate […]
Read More… from Chromatin openness sheds new light on prostate cancer plasticity
New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented by limiting the activity of coregulator proteins. Glucocorticoids regulate vital biological processes by affecting gene encoding through […]
Read More… from New insight into combatting drug-resistant prostate cancer
Two renowned biomedical researchers have been awarded £1 million to undertake world-leading research into diseases such as prostate cancer and mitochondrial disease at Northumbria University. The grant funding has been awarded by the Academy of Medical Sciences as part of its commitment to attract and retain talent from across the globe to take up Professorships […]
Read More… from Medical research receives funding award at Northumbria University
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature. In an early clinical trial, researchers showed that blocking the messages cancer uses to hijack white blood cells can re-sensitise a subset of advanced prostate cancers […]
Read More… from Scientists reverse drug resistance in prostate cancer
Patients with localised prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high. Until now, the precise mechanism behind the spread of the tumour has not been fully explained. But an international research team headed by MedUni Vienna has succeeded in decoding the […]
NHS Prostate Cancer Treatments Surge in England: The number of men having treatment for prostate cancer has jumped by more than a quarter in England in one year, new NHS figures show today. Almost 4,000 men received prostate cancer treatment in August (3,898) compared to just over 3,000 in the same month last year (3,057). […]
Read More… from NHS Prostate Cancer Treatments Surge in England
Cause of metastasis in prostate cancer discovered: Prostate cancers remain localised in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, resulting in approximately 5,000 deaths each year in Austria alone. Medical research has not yet adequately explained why metastases occur in […]
Read More… from Cause of metastasis in prostate cancer discovered
Prostate cancer: “liquid biopsies” allow non-invasive diagnosis of metastatic cancers: In future, newly identified biomarkers could be used alongside imaging techniques for the non-invasive diagnosis of patients with advanced prostate cancer. A research team from the Medical University of Vienna and the Ludwig Boltzmann Institute Applied Diagnostics developed epigenetic biomarkers for the detection of circulating […]
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at ‘intermediate risk’ who can safely avoid immediate treatment and benefit from ‘active surveillance’ instead. A new pilot study published today reveals how urine biomarkers can show the amount of significant cancer in a prostate, highlighting with […]
Read More… from Prostate cancer urine test identifies good prognosis patients